LabCorp風險基金

2022年12月13日

與Labcorp合作——周二,2022年12月13日,衛生和醫生係統領導人正麵臨前所未有的挑戰,而操作在一個不斷變化的醫療格局。支持Labcorp的使命來改善健康和改善生活,Labcorp風險基金投資於早期私營企業經營戰略或相鄰空間發展中小說重要的健康和醫療問題的解決方案。在11月貝克爾醫院評審會議由Labcorp Megann沃恩繼續萎縮,副總裁和Labcorp新合資企業和戰略聯盟的負責人,討論Labcorp風險基金的使命和促進創新的分享故事從五個領導人Labcorp風險基金投資組合。夥伴小組成員是:比爾地堡,CEO,導航癌症悉Kapoor CIO和創始人,HealthEC阿爾伯特·凱利,首席執行官Perthera三個關鍵外賣是:Labcorp工作加速訪問新的科學,技術和創新通過Labcorp風險基金。企業對衝風險,當風險資本有助於組織探索新技術的投資組合。“這幫助我們進入未來的增長機會補充其他工具,如內部研發、合作和並購,“沃恩繼續萎縮”從我們的合作夥伴為我們提供了學習的能力,工作與創業公司操作在潛在增長領域和減輕風險的做我們所有的研發自己或並購太早了。”The 10-year-old Labcorp Venture Fund has invested in a wide range of innovative solutions. Labcorp has helped advance technologies that are making healthcare more convenient, accessible, affordable and personalized. The company is a strategic minority investor in early-stage private companies, directly investing more than $180 million since 2012. Labcorp makes an average of five new investments per year. "We have been investing in companies focused on decentralizing services to make them more convenient and accessible," Vaughn Watters said. "They are working on technologies that can collect biological or data samples in the home and new service models that enable hybrid virtual clinical trials and increased trial participation to bring research to more historically underserved populations." A panel representing five Labcorp Venture Fund investment portfolio companies all share a common mission to improve healthcare. The discussion focused on a few themes, including how ongoing innovation at these companies can improve care delivery and reduce the overall cost of care, enable data-driven decision making for populations and accelerated drug development, or make healthcare more patient-centric and personalized to improve outcomes in all areas of medicine. Among the innovative areas that Labcorp has invested in are: Streamlining communications with cancer patients. "Our platform enables people to take their data and insights and make them actionable," Bunker said. "We impact oncology care on a daily basis across the entire patient base at a practice." Providing aggregated data to all parties. "We take data and bring it to the provider at the practice level, enabling them to reduce costs," Kapoor said. "We take this experience to community practices so they can apply some of the same business rules to their population to drive value-based contracts." Using AI to recommend most up-to-date oncology therapies. "We take test data, put it into algorithms and combine it with expert input. This allows us to provide rank therapies shown to provide quality care and reduce costs more effectively," Kelley said. Moving clinical research to the community. "Although academic medicine and private research sites have done a great job in drug discovery, they are at capacity," Khan said. "We see an opportunity to connect those non-academic health systems and find a way to make it easier for them to conduct research. We have partners that can provide the staff, tech stack and trial availability. This can lead to a different version of drug development in America that is more democratic and more racially representative of the country as well as speed drug development time and reduce the cost." Obtaining labs from the patients' location. "We've created a national, tech-enabled network that allows a seamless deployment of phlebotomists who act as a physical extension of your system into the home," Michelson said. By offering financial resources, expertise and patient data, Labcorp can help accelerate the development of a wide range of healthcare innovations. To register for upcoming webinars, click here .